Papers

1

Total Citations

28

H-Index

1

About

Zhaoyong Yang is a pioneering researcher in protein engineering and synthetic biology, with a primary focus on directed evolution of enzymes for bioactive peptide synthesis. His major contributions center on developing innovative high-throughput screening methods to engineer cyclodipeptide synthases (CDPSs), enzymes that produce diketopiperazine (DKP) scaffolds—key motifs in drug discovery. In his landmark 2022 study, Yang introduced a robotic, label-free mass spectrometric screening approach capable of evaluating 190 possible DKP molecules within a mass window of 115–373 Da. This breakthrough enabled the isolation of a novel F186L CDPS mutant that efficiently synthesizes cyclo(l-Phe-l-Val), a product undetectable in the wild-type enzyme’s repertoire. The work, which has garnered 28 citations, demonstrates a powerful generalizable strategy for engineering enzyme specificity without fluorescent or chromogenic labels. Yang’s approach overcomes traditional limitations in directed evolution by directly detecting product formation, opening new avenues for creating non-natural cyclic peptides with therapeutic potential. His research stands at the intersection of analytical chemistry and synthetic biology, offering transformative tools for discovering novel bioactive molecules.

Research Focus

Key Achievements

1
H-Index
1
Papers
28
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
Directed evolution of a cyclodipeptide synthase with new activities <i>via</i> label-free mass spectrometric screening
28 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago